cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Cabaletta Bio Inc
9 own
12 watching
Current Price
$14.82
$-0.55
(-3.58%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
386.75M
52-Week High
52-Week High
19.34000
52-Week Low
52-Week Low
0.61000
Average Volume
Average Volume
0.5M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization386.75M
icon52-Week High19.34000
icon52-Week Low0.61000
iconAverage Volume0.5M
iconDividend Yield--
iconP/E Ratio--
What does the Cabaletta Bio Inc do?
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company s lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. It has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
Read More
How much money does Cabaletta Bio Inc make?
News & Events about Cabaletta Bio Inc.
Tickeron - Stocks
2 months ago
This indicator may be signaling CABA's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
Tickeron - Stocks
2 months ago
Over the last three days, A.I.dvisor has detected that CABA's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...
Stock Options Channel
2 months ago
Investors considering a purchase of Cabaletta Bio Inc (CABA) stock, but cautious about paying the going market price of 12.74/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2024 ...
Globe Newswire
5 months ago
IND application cleared within 6 months of in-licensing CABA-201 binder CABA-201 data package and experience from prior autoimmune cell therapy INDs informed Phase 1/2 clinical trial design, including the initial dose to be evaluated and the patient dosing intervals PHILADELPHIA, March 31, 2023 (...
Ticker Report
6 months ago
Cabaletta Bio (NASDAQ:CABA Get Rating)s stock had its buy rating restated by equities research analysts at Chardan Capital in a research note issued on Wednesday, Benzinga reports. They currently have a $12.00 price objective on the stock. Chardan Capitals target ...
Frequently Asked Questions
Frequently Asked Questions
What is Cabaletta Bio Inc share price today?
plus_minus_icon
Can Indians buy Cabaletta Bio Inc shares?
plus_minus_icon
How can I buy Cabaletta Bio Inc shares from India?
plus_minus_icon
Can Fractional shares of Cabaletta Bio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Cabaletta Bio Inc stocks?
plus_minus_icon
What is today’s traded volume of Cabaletta Bio Inc?
plus_minus_icon
What is today’s market capitalisation of Cabaletta Bio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Cabaletta Bio Inc?
plus_minus_icon
What percentage is Cabaletta Bio Inc down from its 52-Week High?
plus_minus_icon
What percentage is Cabaletta Bio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$14.82
$-0.55
(-3.58%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
GENERATION BIO CO
GENERATION BIO CO
$3.69
$0.04 (1.10 %)
ALX ONCOLOGY HOLDINGS INC
ALX ONCOLOGY HOLDINGS INC
$4.94
$0.13 (2.70 %)
Chemomab Therapeutics Ltd
Chemomab Therapeutics Ltd
$0.93
$0.02 (2.15 %)
Allakos Inc
Allakos Inc
$2.17
$0.03 (1.17 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
GENERATION BIO CO
GENERATION BIO CO
$3.69
$0.04 (1.10 %)
ALX ONCOLOGY HOLDINGS INC
ALX ONCOLOGY HOLDINGS INC
$4.94
$0.13 (2.70 %)
Chemomab Therapeutics Ltd
Chemomab Therapeutics Ltd
$0.93
$0.02 (2.15 %)
Allakos Inc
Allakos Inc
$2.17
$0.03 (1.17 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00